Who invested in Curon Biopharma?
Curon Biopharma's investors include Temasek Holdings.
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$150Mraised across 1 round since 2018, from 1 source
Curon Biopharma's investors include Temasek Holdings.
Curon Biopharma has raised $150M across 1 round since 2018.
Curon Biopharma's most recent round was a Series A of $150M in Jul 2018.
Its most recent round, $150M in Jul 2018, is also its largest on record.
Curon Biopharma's first round on record, in Jul 2018, was backed by Temasek Holdings.
Curon Biopharma's latest named round is a Series A, in Jul 2018.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.